Explorerโ€บPharmaceutical Researchโ€บBiochemistry
Research PaperResearchia:202610.23022

RiboBridge: protein-conditioned de novo RNA binder structure design

Zhou Zhang

Abstract

Designing RNA molecules that bind to target protein structures requires generating both an RNA conformation and its bound complex geometry, without assuming a predefined binding site. Existing approaches generally model these coupled processes within a unified representation, entangling RNA conformation generation with protein-relative placement. In this work, we introduce RiboBridge, a structure-first framework that separates RNA conformational generation from protein--RNA assembly through cros...

Submitted: October 23, 2026Subjects: Biochemistry; Pharmaceutical Research

Description / Details

Designing RNA molecules that bind to target protein structures requires generating both an RNA conformation and its bound complex geometry, without assuming a predefined binding site. Existing approaches generally model these coupled processes within a unified representation, entangling RNA conformation generation with protein-relative placement. In this work, we introduce RiboBridge, a structure-first framework that separates RNA conformational generation from protein--RNA assembly through cross-frame interaction geometry. RiboBridge first proposes multiple candidate RNA-binding interfaces on the protein surface, generates canonical RNA conformations within a pretrained RNA structural latent space (RiboSphere), and then predicts protein--RNA interaction constraints to bridge the independently defined RNA and protein coordinate frames. The resulting interaction geometry is converted into a geometrically consistent protein-relative pose through rigid placement. We evaluate RiboBridge on a temporally split, sequence-filtered, and redundancy-controlled benchmark of 124 protein--RNA complexes. Under post-hoc interface-correspondence evaluation, where native information is used only after generation to select among already generated predicted-pocket candidates, RiboBridge achieves the highest fNAT and DockQ and the lowest interface and ligand RMSDs among compared methods. Component ablations and stage-wise diagnostics further characterize the contributions of RNA conformational generation, interaction prediction, and rigid placement, identifying the main sources of complex-recovery error.


Source: arXiv:2610.30668v1 - http://arxiv.org/abs/2610.30668v1 PDF: https://arxiv.org/pdf/2610.30668v1 Original Link: http://arxiv.org/abs/2610.30668v1

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper
View Source PDF
Submission Info
Date:
Oct 23, 2026
Topic:
Pharmaceutical Research
Area:
Biochemistry
Comments:
0
Bookmark